Everpure, IncPSTGNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+91.1%
5Y CAGR+29.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+91.1%/yr
Quarterly compound
5Y CAGR
+29.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 21.53% |
| Q4 2025 | -17.33% |
| Q3 2025 | 9.15% |
| Q2 2025 | 3.13% |
| Q1 2025 | 7.46% |
| Q4 2024 | 2.35% |
| Q3 2024 | 0.86% |
| Q2 2024 | 3.74% |
| Q1 2024 | 2.60% |
| Q4 2023 | -0.21% |
| Q3 2023 | -1.53% |
| Q2 2023 | -0.12% |
| Q1 2023 | 3.08% |
| Q4 2022 | 8.64% |
| Q3 2022 | 2.74% |
| Q2 2022 | -0.84% |
| Q1 2022 | 10.03% |
| Q4 2021 | 5.50% |
| Q3 2021 | 6.64% |
| Q2 2021 | 0.76% |
| Q1 2021 | 6.02% |
| Q4 2020 | 7.26% |
| Q3 2020 | 1.96% |
| Q2 2020 | -2.14% |
| Q1 2020 | 7.73% |
| Q4 2019 | -0.33% |
| Q3 2019 | 1.85% |
| Q2 2019 | 8.74% |
| Q1 2019 | 6.44% |
| Q4 2018 | 8.04% |
| Q3 2018 | 7.06% |
| Q2 2018 | 3.99% |
| Q1 2018 | 9.51% |
| Q4 2017 | -0.63% |
| Q3 2017 | 6.01% |
| Q2 2017 | -9.92% |
| Q1 2017 | 17.89% |
| Q4 2016 | 5.08% |
| Q3 2016 | 11.69% |
| Q2 2016 | -2.25% |